ACTIVE SUBSTANCE / INN

GUSELKUMAB

Brand name(s): TREMFYA, Tremfya
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Psoriasis;Crohn Disease;Colitis, Ulcerative
BLA761061
ACTIVE SUBSTANCE
Guselkumab
REGULATORS
FDA · EMA
SPONSORS / MAH
JANSSEN BIOTECH, Janssen-Cilag International NV
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TREMFYABLA761061JANSSEN BIOTECHPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TremfyaJanssen-Cilag International NVAuthorised10/11/2017Psoriasis;Crohn Disease;Colitis, Ulcerative

FULL INTELLIGENCE ON GUSELKUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →